Drug Shortage Report for ENGERIX-B

Last updated on 2019-07-26 History
Report ID 75189
Drug Identification Number 02296454
Brand name ENGERIX-B
Common or Proper name Hepatitis B vaccine (recombinant)
Company Name GLAXOSMITHKLINE INC
Active Ingredient(s) HEPATITIS B SURFACE ANTIGEN
Strength(s) 10MCG
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR
Packaging size 1's
ATC code J07BC
ATC description VIRAL VACCINES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-02-08
Estimated end date 2019-09-16
Actual end date 2019-07-25
Shortage status Resolved
Updated date 2019-07-26
Company comments
Health Canada comments
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2019-07-26 French Compare
v12 2019-07-26 English Compare
v11 2019-07-10 French Compare
v10 2019-07-10 English Compare
v9 2019-05-01 French Compare
v8 2019-05-01 English Compare
v7 2019-04-18 French Compare
v6 2019-04-18 English Compare
v5 2019-03-08 French Compare
v4 2019-03-08 English Compare
v3 2019-02-09 English Compare
v2 2019-02-08 French Compare
v1 2019-02-08 English Compare